Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)

E. M. Gibbs, J. L. Stock, S. C. McCoid, H. A. Stukenbrok, Jeffrey E. Pessin, R. W. Stevenson, A. J. Milici, J. D. McNeish

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

The effects of increased GLUT4 (insulin-regulatable muscle/fat glucose transporter) expression on glucose homeostasis in a genetic model of non- insulin-dependent diabetes mellitus were determined by expressing a human GLUT4 transgene (hGLUT4) in diabetic C57BL/KsJ-db/db mice. A genomic hGLUT4 construct was microinjected directly into pronuclear murine embryos of db/+ matings to maintain the inbred background. Four lines of hGLUT4 transgenic mice were bred to homozygosity at the db locus and all showed a marked reduction of both fasted and fed plasma glucose levels (to ~ 50 and 360 mg/dl, respectively) compared with age-matched nontransgenic db/db mice (~ 215 and 550 mg/dl, respectively), as well as an enhanced disposal of an oral glucose challenge. In situ immunocytochemical localization of GLUT4 protein in muscle from hGLUT4 db/db mice showed elevated plasma membrane-associated GLUT4 protein in the basal state, which markedly increased after an insulin/glucose injection. In contrast, nontransgenic db/db mice had low levels of plasma membrane-associated GLUT4 protein in the basal state with a relatively small increase after an insulin/glucose challenge. Since the intracellular GLUT4 levels in db/db mice were similar to nontransgenic db/+ mice, the glucose transport defect in db/db mice is at the level of glucose transporter translocation. Together, these data demonstrate that GLUT4 upregulation overcomes the glucose transporter translocation defect and alleviates insulin resistance in genetically diabetic mice, thus resulting in markedly improved glycemic control.

Original languageEnglish (US)
Pages (from-to)1512-1518
Number of pages7
JournalJournal of Clinical Investigation
Volume95
Issue number4
StatePublished - 1995
Externally publishedYes

Fingerprint

Facilitative Glucose Transport Proteins
Insulin
Glucose Transporter Type 4
Transgenes
Glucose
Blood Proteins
Membrane Proteins
Cell Membrane
Muscles
Genetic Models
Type 2 Diabetes Mellitus
Transgenic Mice
Insulin Resistance
Homeostasis
Up-Regulation
Embryonic Structures
Fats
Injections

Keywords

  • basal metabolism
  • gene expression
  • genetic models
  • non-insulin-dependent diabetes mellitus
  • upregulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gibbs, E. M., Stock, J. L., McCoid, S. C., Stukenbrok, H. A., Pessin, J. E., Stevenson, R. W., ... McNeish, J. D. (1995). Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). Journal of Clinical Investigation, 95(4), 1512-1518.

Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). / Gibbs, E. M.; Stock, J. L.; McCoid, S. C.; Stukenbrok, H. A.; Pessin, Jeffrey E.; Stevenson, R. W.; Milici, A. J.; McNeish, J. D.

In: Journal of Clinical Investigation, Vol. 95, No. 4, 1995, p. 1512-1518.

Research output: Contribution to journalArticle

Gibbs, EM, Stock, JL, McCoid, SC, Stukenbrok, HA, Pessin, JE, Stevenson, RW, Milici, AJ & McNeish, JD 1995, 'Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)', Journal of Clinical Investigation, vol. 95, no. 4, pp. 1512-1518.
Gibbs, E. M. ; Stock, J. L. ; McCoid, S. C. ; Stukenbrok, H. A. ; Pessin, Jeffrey E. ; Stevenson, R. W. ; Milici, A. J. ; McNeish, J. D. / Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). In: Journal of Clinical Investigation. 1995 ; Vol. 95, No. 4. pp. 1512-1518.
@article{8111dff5814644779be272d0ab7a9a03,
title = "Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)",
abstract = "The effects of increased GLUT4 (insulin-regulatable muscle/fat glucose transporter) expression on glucose homeostasis in a genetic model of non- insulin-dependent diabetes mellitus were determined by expressing a human GLUT4 transgene (hGLUT4) in diabetic C57BL/KsJ-db/db mice. A genomic hGLUT4 construct was microinjected directly into pronuclear murine embryos of db/+ matings to maintain the inbred background. Four lines of hGLUT4 transgenic mice were bred to homozygosity at the db locus and all showed a marked reduction of both fasted and fed plasma glucose levels (to ~ 50 and 360 mg/dl, respectively) compared with age-matched nontransgenic db/db mice (~ 215 and 550 mg/dl, respectively), as well as an enhanced disposal of an oral glucose challenge. In situ immunocytochemical localization of GLUT4 protein in muscle from hGLUT4 db/db mice showed elevated plasma membrane-associated GLUT4 protein in the basal state, which markedly increased after an insulin/glucose injection. In contrast, nontransgenic db/db mice had low levels of plasma membrane-associated GLUT4 protein in the basal state with a relatively small increase after an insulin/glucose challenge. Since the intracellular GLUT4 levels in db/db mice were similar to nontransgenic db/+ mice, the glucose transport defect in db/db mice is at the level of glucose transporter translocation. Together, these data demonstrate that GLUT4 upregulation overcomes the glucose transporter translocation defect and alleviates insulin resistance in genetically diabetic mice, thus resulting in markedly improved glycemic control.",
keywords = "basal metabolism, gene expression, genetic models, non-insulin-dependent diabetes mellitus, upregulation",
author = "Gibbs, {E. M.} and Stock, {J. L.} and McCoid, {S. C.} and Stukenbrok, {H. A.} and Pessin, {Jeffrey E.} and Stevenson, {R. W.} and Milici, {A. J.} and McNeish, {J. D.}",
year = "1995",
language = "English (US)",
volume = "95",
pages = "1512--1518",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4)

AU - Gibbs, E. M.

AU - Stock, J. L.

AU - McCoid, S. C.

AU - Stukenbrok, H. A.

AU - Pessin, Jeffrey E.

AU - Stevenson, R. W.

AU - Milici, A. J.

AU - McNeish, J. D.

PY - 1995

Y1 - 1995

N2 - The effects of increased GLUT4 (insulin-regulatable muscle/fat glucose transporter) expression on glucose homeostasis in a genetic model of non- insulin-dependent diabetes mellitus were determined by expressing a human GLUT4 transgene (hGLUT4) in diabetic C57BL/KsJ-db/db mice. A genomic hGLUT4 construct was microinjected directly into pronuclear murine embryos of db/+ matings to maintain the inbred background. Four lines of hGLUT4 transgenic mice were bred to homozygosity at the db locus and all showed a marked reduction of both fasted and fed plasma glucose levels (to ~ 50 and 360 mg/dl, respectively) compared with age-matched nontransgenic db/db mice (~ 215 and 550 mg/dl, respectively), as well as an enhanced disposal of an oral glucose challenge. In situ immunocytochemical localization of GLUT4 protein in muscle from hGLUT4 db/db mice showed elevated plasma membrane-associated GLUT4 protein in the basal state, which markedly increased after an insulin/glucose injection. In contrast, nontransgenic db/db mice had low levels of plasma membrane-associated GLUT4 protein in the basal state with a relatively small increase after an insulin/glucose challenge. Since the intracellular GLUT4 levels in db/db mice were similar to nontransgenic db/+ mice, the glucose transport defect in db/db mice is at the level of glucose transporter translocation. Together, these data demonstrate that GLUT4 upregulation overcomes the glucose transporter translocation defect and alleviates insulin resistance in genetically diabetic mice, thus resulting in markedly improved glycemic control.

AB - The effects of increased GLUT4 (insulin-regulatable muscle/fat glucose transporter) expression on glucose homeostasis in a genetic model of non- insulin-dependent diabetes mellitus were determined by expressing a human GLUT4 transgene (hGLUT4) in diabetic C57BL/KsJ-db/db mice. A genomic hGLUT4 construct was microinjected directly into pronuclear murine embryos of db/+ matings to maintain the inbred background. Four lines of hGLUT4 transgenic mice were bred to homozygosity at the db locus and all showed a marked reduction of both fasted and fed plasma glucose levels (to ~ 50 and 360 mg/dl, respectively) compared with age-matched nontransgenic db/db mice (~ 215 and 550 mg/dl, respectively), as well as an enhanced disposal of an oral glucose challenge. In situ immunocytochemical localization of GLUT4 protein in muscle from hGLUT4 db/db mice showed elevated plasma membrane-associated GLUT4 protein in the basal state, which markedly increased after an insulin/glucose injection. In contrast, nontransgenic db/db mice had low levels of plasma membrane-associated GLUT4 protein in the basal state with a relatively small increase after an insulin/glucose challenge. Since the intracellular GLUT4 levels in db/db mice were similar to nontransgenic db/+ mice, the glucose transport defect in db/db mice is at the level of glucose transporter translocation. Together, these data demonstrate that GLUT4 upregulation overcomes the glucose transporter translocation defect and alleviates insulin resistance in genetically diabetic mice, thus resulting in markedly improved glycemic control.

KW - basal metabolism

KW - gene expression

KW - genetic models

KW - non-insulin-dependent diabetes mellitus

KW - upregulation

UR - http://www.scopus.com/inward/record.url?scp=0028942658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028942658&partnerID=8YFLogxK

M3 - Article

C2 - 7706456

AN - SCOPUS:0028942658

VL - 95

SP - 1512

EP - 1518

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -